Advanced Neuromodulation Systems receives European approval
for pain-control device

18 January 2006

Plano, Texas, USA. Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc. (NYSE:STJ), has received European CE Mark approval for its spinal cord stimulation (SCS) device for managing chronic pain.

The Rapid Programmer 3.0 features two new technologies for delivering stimulation to pain patients:

  • Dynamic MultiStim, which allows for real-time adjustments to multiple areas of pain. This is especially useful when patients have complex pain patterns, such as a combination of back and leg pain.
  • Active Balancing enables fine tuning of stimulation levels in multiple coverage areas.

Coinciding with this approval, ANS has launched an upgraded version of its rechargeable spinal cord stimulation device, the Eon with NeuroDynamix technology.

Spinal cord stimulators like Eon are used to treat patients suffering with chronic intractable pain. These “pacemakers for pain” interrupt the pain signals’ pathway to the brain by delivering low intensity electrical pulses to selective nerve fibres along the spinal cord. More than 30,000 patients worldwide have been implanted with ANS neurostimulation systems to help alleviate their chronic pain.

“The enhanced Eon and the new Rapid Programmer platform work together as an integrated system to provide clinicians greater speed, power, efficiency and precision for helping patients address complex pain,” said Chris Chavez, president of Advanced Neuromodulation Systems.

To top

To top